The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees

The rapid replacement of Omicron BA.1 by BA.2 sublineage is very alarming, raising the question of whether BA.2 can escape the immunity acquired after BA.1 infection. We compared the neutralizing activity toward the Omicron BA.1 and BA.2 sub-lineages in five groups: COVID-19 patients; subjects who h...

Full description

Bibliographic Details
Main Authors: Francesca Dapporto, Margherita Leonardi, Claudia Maria Trombetta, Claudia Semplici, Pietro Piu, Giulia Piccini, Linda Benincasa, Serena Marchi, Emanuele Andreano, Piero Lovreglio, Nicola Buonvino, Nicola Decaro, Angela Stufano, Eleonora Lorusso, Emilio Bombardieri, Antonella Ruello, Simonetta Viviani, Rino Rappuoli, Eleonora Molesti, Alessandro Manenti, Emanuele Montomoli
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
hybrid immunity
mrna booster
neutralizing antibodies
omicron ba.1
omicron ba.2
sars-cov-2
sars-cov-2 vaccines
Online Access:http://dx.doi.org/10.1080/21645515.2022.2129196

Internet

http://dx.doi.org/10.1080/21645515.2022.2129196

Similar Items